Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

A First-in-Human Phase 1/2 Study of the Menin-KMT2A(MLL1) Inhibitor BN104 in Adult Patients with Relapsed or Refractory Acute Leukemia

Blood (2024) 144 (Supplement 1): 2879.

https://doi.org/10.1182/blood-2024-198959

Published: 2024

Journal Articles

SLC25A1 Reprograms Mitochondrial and Fatty Acid Metabolism to Promote the Progression of Acute Myeloid Leukemia

Xiaojing Yan, Miao Chen, Yuan Tao, Sijing Kang, Pengjie Yue, Rui Ge

Blood (2024) 144 (Supplement 1): 2733.

https://doi.org/10.1182/blood-2024-203227

Published: 2024

Journal Articles

An Open-Label, Multicenter, Phase Ib Study of the Anti-TIM3 Monoclonal Antibody BC3402 in Combination with Azacitidine in Patients with Higher-Risk Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML)

Bing Li, Qing-song Yin, Xiaojing Yan, Min Hang, Hai-Jun Guo, Sheng Wang, Yi-wei Wang, Yong-jiang Hei, Zhi-jian Xiao

Blood (2024) 144 (Supplement 1): 4135.

https://doi.org/10.1182/blood-2024-201319

Published: 2024

Journal Articles

SG301, a Novel Anti-CD38 Monoclonal Antibody, in Patients with Relapsed/Refractory Multiple Myeloma: A First-in-Human, Multicentre, Phase 1 Trial

Blood (2024) 144 (Supplement 1): 4746.

https://doi.org/10.1182/blood-2024-199381

Published: 2024

Journal Articles

The Efficacy and Survival Analysis of Fit-AML Patients Treated with Venetoclax Combined with Hypomethylating Agents (VEN-HMAs)

Ludan Zhang, Jingchen Sui, Pingping Wang, Deng Pan, Xiaojing Yan

Blood (2024) 144 (Supplement 1): 5985.

https://doi.org/10.1182/blood-2024-209635

Published: 2024

Journal Articles

Early Bone Marrow Evaluation of Venetoclax Plus Hypomethylating Agents in Acute Myeloid Leukemia Patients

Ludan Zhang, Pingping Wang, Deng Pan, Xiaojing Yan

Blood (2024) 144 (Supplement 1): 5984.

https://doi.org/10.1182/blood-2024-209559

Published: 2024

Journal Articles

Prognosis Prediction By Two Single Factors Could Predict the Survival of PCNSL Patients Received HD-MTX Therapy without HSCT

Bian Renjie, Yi Qu, Danyang Wu, Jinxiang Yu, Xiaoxue Wang, Lei Wang, Juan He, Jun Wang, Xiaojing Yan

Blood (2024) 144 (Supplement 1): 6466.

https://doi.org/10.1182/blood-2024-204890

Published: 2024

Journal Articles

Asymptomatic Multicentric Castleman Disease: A Potential Early Stage of Idiopathic Mcd

Blood (2024) 144 (Supplement 1): 4417.

https://doi.org/10.1182/blood-2024-204513

Published: 2024

Journal Articles

The Treatment Pathways, Patient Characteristics and Outcomes in Patients with CD30-Expressing Lymphoma from China: A Multi-Center, Non-Interventional, Retrospective Study

Yi Miao, Wenyu Li, Kaiyang Ding, Fei Li, Xiaojing Yan, Xiaoxi Zhou, Caixia Li, Guohui Cui, Liqun Zou, Bing Xiu, Xiangxiang Zhou, Liansheng Zhang, Fuling Zhou, Hongmei Jing, Jianli Wang, Ziheng Guo, Jianyong Li

Blood (2024) 144 (Supplement 1): 6372.

https://doi.org/10.1182/blood-2024-201339

Published: 2024

Journal Articles

Preliminary Results of a Phase 2 Study of IMM01 Combined with Azacitidine (AZA) As the First-Line Treatment in Adult Patients with Chronic Myelomonocytic Leukemia (CMML)

Hongyan Tong, Sujun Gao, Wei Yang, Junmin Li, Qingsong Yin, Xingli Zhao, Xiaojing Yan, Sanfang Tu, Fei Li, Haiping Yang, Ronghua Hu, Shaoyuan Wang, Zheng Dong, Yixuan Yang, Zhenjiu Wang, Qiying Lu, Wenzhi Tian, Zhijian Xiao, Jianxiang Wang

Blood (2023) 142 (Supplement 1): 1859.

https://doi.org/10.1182/blood-2023-181501

Published: 2023

Journal Articles

Preliminary Results of a Phase 2 Study of IMM01 Combined with Azacitidine (AZA) As the First-Line Treatment in Adult Patients with Higher Risk Myelodysplastic Syndromes (MDS)

Blood (2023) 142 (Supplement 1): 320.

https://doi.org/10.1182/blood-2023-174420

Published: 2023

Journal Articles

Health-Related Quality of Life (HRQL) in Cutaneous T-Cell Lymphoma: Psychological Burden and Influencing Factors from Mycosis Fungoides and Sézary Syndrome Patients in China

Tun-Ying Hsu, Huiping Sun, Zhiming Li, Wenrong Huang, Linna Xie, Xiaojing Yan, Haifeng Zhao, Ki Hyon Kim, Yuankai Shi

Blood (2023) 142 (Supplement 1): 7354.

https://doi.org/10.1182/blood-2023-179638

Published: 2023

Journal Articles

Selinexor in Combination with Venetoclax and Azacitidine for Newly Diagnosed (ND) Unfit Acute Myeloid Leukemia (AML): A Multicenter, Open-Label Prospective Study

Li Yang, Fangli Chen, Hong Liang, Yunsong Bai, Wenzhong Wu, Xiaojing Yan, Jinhai Ren, Si Li, Yang Yu, Laigen Tong, Deng Pan, Ligen Liu

Blood (2023) 142 (Supplement 1): 55.

https://doi.org/10.1182/blood-2023-184581

Published: 2023

Journal Articles

Mitoxantrone Hydrochloride Liposome Containing Regimen in Patients with Adult Acute Lymphoblastic Leukemia: A Multicenter, Retrospective, Real-World Study

JUN MA, Tiejun Gong, Donglu Zhao, Xiaoyu Zhu, Xiaojing Yan, Junjie Ma, Yun Cai, HongXiang Wang, Mei Hong, Li Liu, Qiang Song, Xin Wang

Blood (2023) 142 (Supplement 1): 5897.

https://doi.org/10.1182/blood-2023-187864

Published: 2023

Journal Articles

A National, Multicenter, Retrospective Study of Castleman Disease Implementing Cdcn Criteria: 'severe Imcd' Is Indeed Severe

Blood (2022) 140 (Supplement 1): 3609–3611.

https://doi.org/10.1182/blood-2022-158675

Published: 2022

Journal Articles

Molecular Biomarker Analyses for Exploring the Therapeutic Mechanism of Lemzoparlimab and Azacitidine (AZA) in Newly Diagnosed Higher Risk Myelodysplastic Syndrome (HR-MDS)

Blood (2022) 140 (Supplement 1): 8821–8822.

https://doi.org/10.1182/blood-2022-163880

Published: 2022

Journal Articles

Trial in Progress: A Perspective Study of Pan-Oral Triplet Regimen Pomalidomide, Ixazomib and Dexamethasone in Relapsed or Refractory Myeloma Patients

Miao Chen, Li Bao, Wenming Chen, Rong Fu, Rong Guo, Hongmei Jing, Hui Liu, Qinhua Liu, Yanping Ma, Xiuli SUN, Wei Wang, Yafei Wang, Xiaojing Yan, Jiang Qian, Junling Zhuang

Blood (2021) 138 (Supplement 1): 4783.

https://doi.org/10.1182/blood-2021-148237

Published: 2021

Journal Articles

Long Noncoding RNA HOXA-AS2 As a Predictor of Acute Myeloid Leukemia: Clinical Association between HOXA-AS2 Expression and Its Role in Leukemic Cell Growth

Xiaojing Yan, MD PhD, Yi Qu

Blood (2018) 132 (Supplement 1): 5131.

https://doi.org/10.1182/blood-2018-99-115744

Published: 2018

Journal Articles

NPM1 Mutation Contributes to Hematological Dysfunction By Disrupting H3K79 Methylation

Jie Xu, MD, PhD, Wu Zhang, PhD, Xiaojing Yan, MD PhD, Chen Zhao, Jiang Zhu, MD PhD, Zhu Chen, Sai-Juan Chen, MD, PhD, Jiong Hu, Sr., Doctor

Blood (2016) 128 (22): 2702.

https://doi.org/10.1182/blood.V128.22.2702.2702

Published: 2016

Journal Articles

Arsenic Binding to RBCC Domain Modulates Oncogenic PML-RARa and Wild-Type PML as a Key Molecular Mechanism of Arsenic Trioxide Treatment for APL.

Xiaowei Zhang, Xiaojing Yan, Feifei Yang, Ziren Zhou, Ziyu Wu, Hongbin Sun, Wenxue Liang, Aixin Song, Qiuhua Huang, Guangbiao Zhou, Jianhua Tong, Yan Zhang, Jihui Wu, Hongyu Hu, Saijuan Chen, Zhu Chen

Blood (2009) 114 (22): 592.

https://doi.org/10.1182/blood.V114.22.592.592

Published: 2009

NARROW

A First-in-Human Phase 1/2 Study of the Menin-KMT2A(MLL1) Inhibitor BN104 in Adult Patients with Relapsed or Refractory Acute Leukemia

SLC25A1 Reprograms Mitochondrial and Fatty Acid Metabolism to Promote the Progression of Acute Myeloid Leukemia

An Open-Label, Multicenter, Phase Ib Study of the Anti-TIM3 Monoclonal Antibody BC3402 in Combination with Azacitidine in Patients with Higher-Risk Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML)

SG301, a Novel Anti-CD38 Monoclonal Antibody, in Patients with Relapsed/Refractory Multiple Myeloma: A First-in-Human, Multicentre, Phase 1 Trial

The Efficacy and Survival Analysis of Fit-AML Patients Treated with Venetoclax Combined with Hypomethylating Agents (VEN-HMAs)

Early Bone Marrow Evaluation of Venetoclax Plus Hypomethylating Agents in Acute Myeloid Leukemia Patients

Prognosis Prediction By Two Single Factors Could Predict the Survival of PCNSL Patients Received HD-MTX Therapy without HSCT

Asymptomatic Multicentric Castleman Disease: A Potential Early Stage of Idiopathic Mcd

The Treatment Pathways, Patient Characteristics and Outcomes in Patients with CD30-Expressing Lymphoma from China: A Multi-Center, Non-Interventional, Retrospective Study

Preliminary Results of a Phase 2 Study of IMM01 Combined with Azacitidine (AZA) As the First-Line Treatment in Adult Patients with Chronic Myelomonocytic Leukemia (CMML)

Preliminary Results of a Phase 2 Study of IMM01 Combined with Azacitidine (AZA) As the First-Line Treatment in Adult Patients with Higher Risk Myelodysplastic Syndromes (MDS)

Health-Related Quality of Life (HRQL) in Cutaneous T-Cell Lymphoma: Psychological Burden and Influencing Factors from Mycosis Fungoides and Sézary Syndrome Patients in China

Selinexor in Combination with Venetoclax and Azacitidine for Newly Diagnosed (ND) Unfit Acute Myeloid Leukemia (AML): A Multicenter, Open-Label Prospective Study

Mitoxantrone Hydrochloride Liposome Containing Regimen in Patients with Adult Acute Lymphoblastic Leukemia: A Multicenter, Retrospective, Real-World Study

A National, Multicenter, Retrospective Study of Castleman Disease Implementing Cdcn Criteria: 'severe Imcd' Is Indeed Severe

Molecular Biomarker Analyses for Exploring the Therapeutic Mechanism of Lemzoparlimab and Azacitidine (AZA) in Newly Diagnosed Higher Risk Myelodysplastic Syndrome (HR-MDS)

Trial in Progress: A Perspective Study of Pan-Oral Triplet Regimen Pomalidomide, Ixazomib and Dexamethasone in Relapsed or Refractory Myeloma Patients

Long Noncoding RNA HOXA-AS2 As a Predictor of Acute Myeloid Leukemia: Clinical Association between HOXA-AS2 Expression and Its Role in Leukemic Cell Growth

NPM1 Mutation Contributes to Hematological Dysfunction By Disrupting H3K79 Methylation

Arsenic Binding to RBCC Domain Modulates Oncogenic PML-RARa and Wild-Type PML as a Key Molecular Mechanism of Arsenic Trioxide Treatment for APL.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only